Viewing Study NCT05627232


Ignite Creation Date: 2025-12-24 @ 9:54 PM
Ignite Modification Date: 2026-01-02 @ 8:24 AM
Study NCT ID: NCT05627232
Status: SUSPENDED
Last Update Posted: 2025-11-03
First Post: 2022-11-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tazemetostat and Palbociclib With CPX-351for R/R AML
Sponsor: Thomas Jefferson University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module